Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MV-CHIK Vaccine Dose Finding Study
NCT02861586Phase 2Completed
- Sponsor
- Themis Bioscience
- Start
- Aug 2016
- Primary completion
- Sep 2017
- Modality
- Viral Vectors, Live Attenuated Vaccines
- Countries
- 2
01
Overview
A Phase 2 trial of MV-CHIK in chikungunya virus infection, sponsored by Themis Bioscience. Started Aug 2016; status: completed.
02
Drugs
MV-CHIK
03
Conditions
chikungunya virus infection
Beyond the preview
Go deeper on NCT02861586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02861586.